All Stories

  1. Towards quantifying biomarkers for respiratory distress in preterm infants: Machine learning on mid infrared spectroscopy of lipid mixtures

    Article • Talanta, August 2024, Elsevier

    Dr Ahilanandan Dushianthan

  2. Particles in Exhaled Air (PExA): Clinical Uses and Future Implications

    Article • Diagnostics, May 2024, MDPI AG

    Dr Ahilanandan Dushianthan

  3. Oxidative stress, redox status and surfactant metabolism in mechanically ventilated patients receiving different approaches to oxygen therapy (MecROX): An observational study protocol for mechanistic evaluation

    Article • NIHR Open Research, April 2024, National Institute for Health Research

    Dr Ahilanandan Dushianthan

  4. Particles in Exhaled Air (PExA): Clinical Uses and Future Implications

    Article • April 2024, MDPI AG

    Dr Ahilanandan Dushianthan

  5. Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses

    Article • Nature Communications, April 2024, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  6. Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease

    Article • Nature Immunology, April 2024, Springer Science + Business Media

    Dr Ahilanandan Dushianthan, MD Pilar Rivera Ortega, Dr Cherie Armour

  7. In Vivo Cellular Phosphatidylcholine Kinetics of CD15+ Leucocytes and CD3+ T-Lymphocytes in Adults with Acute Respiratory Distress Syndrome

    Article • Cells, February 2024, MDPI AG

    Dr Ahilanandan Dushianthan

  8. Management of Acute Life-Threatening Asthma Exacerbations in the Intensive Care Unit

    Article • Applied Sciences, January 2024, MDPI AG

    Dr Ahilanandan Dushianthan

  9. Non-Invasive Ventilation for Community-Acquired Pneumonia: Outcomes and Predictors of Failure from an ICU Cohort

    Article • Medicina, December 2023, MDPI AG

    Dr Ahilanandan Dushianthan

  10. Organisation and delivery of a dedicated multidisciplinary prone ventilation team in the intensive care unit: Strategies and lessons from COVID-19

    Article • PLoS ONE, December 2023, PLOS

    Dr Ahilanandan Dushianthan

  11. Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19

    Article • The Journal of Infectious Diseases, December 2023, Oxford University Press (OUP)

    Dr Ahilanandan Dushianthan

  12. Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses

    Article • Nature Communications, December 2023, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  13. Simvastatin in Critically Ill Patients with Covid-19

    Article • New England Journal of Medicine, December 2023, New England Journal of Medicine (NEJM/MMS)

    Dr Ahilanandan Dushianthan

  14. A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)

    Article • Scientific Reports, November 2023, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  15. Severe Parainfluenza Viral Infection—A Retrospective Study of Adult Intensive Care Patients

    Article • Journal of Clinical Medicine, November 2023, MDPI AG

    Dr Ahilanandan Dushianthan

  16. Intravenous Vitamin C for Patients Hospitalized With COVID-19

    Article • JAMA, November 2023, American Medical Association (AMA)

    Dr Ahilanandan Dushianthan

  17. Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia

    Article • Medical Sciences, November 2023, MDPI AG

    Dr Ahilanandan Dushianthan

  18. International Pediatric COVID-19 Severity Over the Course of the Pandemic

    Article • JAMA Pediatrics, October 2023, American Medical Association (AMA)

    Dr Ahilanandan Dushianthan

  19. Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions

    Article • Diagnostics, September 2023, MDPI AG

    Dr Ahilanandan Dushianthan

  20. Predictors of mortality for major trauma patients in intensive care: A retrospective cohort study

    Article • F1000Research, August 2023, Faculty of 1000, Ltd.

    Dr Ahilanandan Dushianthan

  21. Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial

    Article • American Journal of Respiratory and Critical Care Medicine, August 2023, American Thoracic Society

    Dr Ahilanandan Dushianthan

  22. Prone Positioning in Mechanically Ventilated COVID-19 Patients: Timing of Initiation and Outcomes

    Article • Journal of Clinical Medicine, June 2023, MDPI AG

    Dr Ahilanandan Dushianthan

  23. Provision of Microbiology, Infection Services and Antimicrobial Stewardship in Intensive Care: A Survey across the Critical Care Networks in England and Wales

    Article • Antibiotics, April 2023, MDPI AG

    Dr Ahilanandan Dushianthan

  24. Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19

    Article • JAMA, April 2023, American Medical Association (AMA)

    Dr Ahilanandan Dushianthan

  25. The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection

    Article • March 2023, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  26. Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

    Article • JAMA, January 2023, American Medical Association (AMA)

    Dr Ahilanandan Dushianthan

  27. Detailed Analysis of Primary Non-invasive Respiratory Support and Outcomes of Subjects With COVID-19 Acute Hypoxaemic Respiratory Failure

    Article • Cureus, December 2022, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  28. The association between iron deficiency and outcomes: a secondary analysis of the intravenous iron therapy to treat iron deficiency anaemia in patients undergoing major abdominal surgery (PREVENTT) trial

    Article • Anaesthesia, December 2022, Wiley

    Dr Ahilanandan Dushianthan

  29. Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: Results of a randomised controlled trial

    Article • Journal of Infection, December 2022, Elsevier

    Dr Ahilanandan Dushianthan

  30. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

    Article • EBioMedicine, December 2022, Elsevier

    MD Pilar Rivera Ortega, Mark Philip Cassar, Prof. Markus Ralser, Dr Ahilanandan Dushianthan, Dr Cherie Armour

  31. Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐19

    Article • Immunology, November 2022, Wiley

    Dr Ahilanandan Dushianthan

  32. Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study

    Article • Open Forum Infectious Diseases, October 2022, Oxford University Press (OUP)

    Dr Ahilanandan Dushianthan

  33. Body mass index and clinical outcome of severe COVID-19 patients with acute hypoxic respiratory failure: Unravelling the “obesity paradox” phenomenon

    Article • Clinical Nutrition ESPEN, October 2022, Elsevier

    Dr Ahilanandan Dushianthan

  34. Aspergillus in COVID-19 intensive care unit; what is lurking above your head?

    Article • Journal of Infection Prevention, September 2022, SAGE Publications

    Dr Ahilanandan Dushianthan

  35. Caring for COVID‐19 patients through a pandemic in the intensive care setting: A narrative review

    Article • WIREs Mechanisms of Disease, July 2022, Wiley

    Dr Ahilanandan Dushianthan

  36. Antimicrobial stewardship programmes focused on de-escalation: a narrative review of efficacy and risks

    Article • Journal of Emergency and Critical Care Medicine, July 2022, AME Publishing Company

    Dr Ahilanandan Dushianthan

  37. Dynamic blood oxygen indices in mechanically ventilated COVID-19 patients with acute hypoxic respiratory failure: A cohort study

    Article • PLoS ONE, June 2022, PLOS

    Prof Michael M Grocott, Dr Ahilanandan Dushianthan

  38. Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission

    Article • Open Forum Infectious Diseases, May 2022, Oxford University Press (OUP)

    Dr Ahilanandan Dushianthan

  39. Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study

    Article • Scientific Reports, April 2022, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  40. Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19

    Article • JAMA, April 2022, American Medical Association (AMA)

    Dr Ahilanandan Dushianthan

  41. Compassionate use of Pulmonary Vasodilators in Acute Severe Hypoxic Respiratory Failure due to COVID-19

    Article • Journal of Intensive Care Medicine, April 2022, SAGE Publications

    Dr Ahilanandan Dushianthan

  42. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

    Article • The Lancet Digital Health, April 2022, Elsevier

    Dr Ahilanandan Dushianthan

  43. Improving physical function of patients following intensive care unit admission (EMPRESS): protocol of a randomised controlled feasibility trial

    Article • BMJ Open, April 2022, BMJ

    Dr Ahilanandan Dushianthan, Prof Nicholas Hart

  44. Severe COVID‐19 pneumonia in an intensive care setting and comparisons with historic severe viral pneumonia due to other viruses

    Article • The Clinical Respiratory Journal, February 2022, Wiley

    Dr Ahilanandan Dushianthan

  45. Rapid Phospholipid Turnover after Surfactant Nebulization in Severe COVID-19 Infection: A Randomized Clinical Trial

    Article • American Journal of Respiratory and Critical Care Medicine, February 2022, American Thoracic Society

    Dr Ahilanandan Dushianthan

  46. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

    Article • Cell, February 2022, Elsevier

    Michael Olanipekun, Dr Ahilanandan Dushianthan

  47. Biomarker identification using dynamic time warping analysis: a longitudinal cohort study of patients with COVID-19 in a UK tertiary hospital

    Article • BMJ Open, February 2022, BMJ

    Dr Ahilanandan Dushianthan

  48. Wave comparisons of clinical characteristics and outcomes of COVID-19 admissions - Exploring the impact of treatment and strain dynamics

    Article • Journal of Clinical Virology, January 2022, Elsevier

    Dr Ahilanandan Dushianthan

  49. Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19

    Article • Heart, December 2021, BMJ

    Michael Olanipekun, Dr Ahilanandan Dushianthan

  50. Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

    Article • Thorax, November 2021, BMJ

    Dr Ahilanandan Dushianthan

  51. Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19

    Article • JAMA, November 2021, American Medical Association (AMA)

    Dr Ahilanandan Dushianthan

  52. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

    Article • iScience, November 2021, Elsevier

    Michael Olanipekun, Dr Ahilanandan Dushianthan

  53. A prenylated dsRNA sensor protects against severe COVID-19

    Article • Science, October 2021, American Association for the Advancement of Science

    Dr Ahilanandan Dushianthan, Professor Ruth Frances Jarrett

  54. Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study

    Article • Nephrology Dialysis Transplantation, October 2021, Oxford University Press (OUP)

    Dr Ahilanandan Dushianthan

  55. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study

    Article • BMJ Open, October 2021, BMJ

    Dr Ahilanandan Dushianthan

  56. Can a quantitative assessment of SARS-CoV-2 PCR predict degree of severity and outcomes in critical care patients with COVID-19?

    Article • Infezioni in Medicina, September 2021, Edizioni Internazionali srl, Divisione EDIMES Edizioni Medico-Scientifiche

    Dr Ahilanandan Dushianthan

  57. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

    Article • New England Journal of Medicine, August 2021, New England Journal of Medicine (NEJM/MMS)

    Dr Ahilanandan Dushianthan

  58. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

    Article • New England Journal of Medicine, August 2021, New England Journal of Medicine (NEJM/MMS)

    Dr Ahilanandan Dushianthan

  59. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

    Article • The Lancet Microbe, August 2021, Elsevier

    Dr Ahilanandan Dushianthan

  60. Predictive Role of Haematological Determinants on Outcomes of Critically Ill COVID-19 Patients Admitted to Intensive Care Unit

    Article • Cureus, July 2021, Cureus, Inc.

    Dr Ahilanandan Dushianthan

  61. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

    Article • Intensive Care Medicine, July 2021, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  62. Mapping the human genetic architecture of COVID-19

    Article • Nature, July 2021, Springer Science + Business Media

    Michael Olanipekun, Dr Ahilanandan Dushianthan, Roberta Russo

  63. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

    Article • The Lancet, July 2021, Elsevier

    Michael Olanipekun, Dr Ahilanandan Dushianthan

  64. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

    Article • The Lancet Respiratory Medicine, July 2021, Elsevier

    Dr Ahilanandan Dushianthan

  65. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

    Article • The Lancet Rheumatology, July 2021, Elsevier

    Dr Ahilanandan Dushianthan

  66. Severe COVID-19 pneumonia in an intensive care setting and comparisons with historic severe viral pneumonia due to other viruses

    Article • June 2021, Research Square

    Dr Ahilanandan Dushianthan

  67. Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

    Article • BMC Health Services Research, June 2021, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  68. Methodology to detect oxidised phospholipids and their relevance in disease

    Article • Biochemical Society Transactions, May 2021, Portland Press Ltd.

    Dr Ahilanandan Dushianthan

  69. Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19

    Article • Thrombosis Research, May 2021, Elsevier

    Dr Ahilanandan Dushianthan

  70. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

    Article • New England Journal of Medicine, April 2021, New England Journal of Medicine (NEJM/MMS)

    Dr Ahilanandan Dushianthan

  71. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

    Article • The Lancet Respiratory Medicine, April 2021, Elsevier

    Dr Ahilanandan Dushianthan

  72. Intensive care physicians’ perceptions of the diagnosis & management of patients with acute hypoxic respiratory failure associated with COVID-19: A UK based survey

    Article • Journal of the Intensive Care Society, March 2021, SAGE Publications

    Dr Ahilanandan Dushianthan

  73. Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study

    Article • BMC Nephrology, March 2021, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  74. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19

    Article • Science Immunology, March 2021, American Association for the Advancement of Science

    Dr Ahilanandan Dushianthan

  75. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

    Article • The Lancet Respiratory Medicine, March 2021, Elsevier

    Dr Ahilanandan Dushianthan

  76. Vitamin D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2021, De Gruyter

    Laurence Orchard, Dr Ahilanandan Dushianthan

  77. Research Evaluation Alongside Clinical Treatment in COVID-19 (REACT COVID-19): an observational and biobanking study

    Article • BMJ Open, January 2021, BMJ

    Dr Ahilanandan Dushianthan

  78. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

    Article • American Journal of Respiratory and Critical Care Medicine, December 2020, American Thoracic Society

    MD Pilar Rivera Ortega, Dr Ahilanandan Dushianthan

  79. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial

    Article • Trials, December 2020, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  80. Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020

    Article • Eurosurveillance, October 2020, European Centre for Disease Control and Prevention (ECDC)

    Professor Nigel James Temperton, Dr Ahilanandan Dushianthan

  81. Goal-directed haemodynamic therapy (GDHT) in surgical patients: systematic review and meta-analysis of the impact of GDHT on post-operative pulmonary complications

    Article • Perioperative Medicine, October 2020, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  82. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19

    Article • JAMA, October 2020, American Medical Association (AMA)

    Dr Ahilanandan Dushianthan

  83. In-hospital cardiac arrest audit: An audit reviewing outcomes

    Article • Resuscitation, October 2020, Elsevier

    Dr Ahilanandan Dushianthan

  84. Noninvasive ventilation for COVID-19-associated acute hypoxaemic respiratory failure: experience from a single centre

    Article • British Journal of Anaesthesia, October 2020, Elsevier

    Dr Ahilanandan Dushianthan

  85. Prediction of mortality in critically-ill elderly trauma patients: a single centre retrospective observational study and comparison of the performance of trauma scores

    Article • Scandinavian Journal of Trauma Resuscitation and Emergency Medicine, September 2020, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  86. Inflammatory phenotyping predicts clinical outcome in COVID-19

    Article • September 2020, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  87. Recurrent Pneumothorax in a Critically Ill Ventilated COVID-19 Patient

    Article • Case Reports in Critical Care, September 2020, Hindawi Publishing Corporation

    Dr Ahilanandan Dushianthan

  88. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

    Article • BMJ, September 2020, BMJ

    Dr Ahilanandan Dushianthan

  89. Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit

    Article • Journal of Global Antimicrobial Resistance, September 2020, Elsevier

    Dr Ahilanandan Dushianthan

  90. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study

    Article • BMJ, August 2020, BMJ

    Dr Ahilanandan Dushianthan

  91. Conscious prone positioning during non-invasive ventilation in COVID-19 patients: experience from a single centre

    Article • F1000Research, July 2020, Faculty of 1000, Ltd.

    Dr Ahilanandan Dushianthan

  92. Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID‐19 pneumonia

    Article • British Journal of Haematology, July 2020, Wiley

    Dr Ahilanandan Dushianthan

  93. Clinical characteristics of children and young people hospitalised with covid-19 in the United Kingdom: prospective multicentre observational cohort study

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Dr Ahilanandan Dushianthan

  94. Clinical characteristics and outcome of critically ill COVID-19 patients with Acute Kidney Injury: A single centre cohort study

    Article • July 2020, Research Square

    Dr Ahilanandan Dushianthan

  95. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

    Article • BMJ, May 2020, BMJ

    Dr Ahilanandan Dushianthan

  96. P196 Outcome of COPD patients started on inpatient domiciliary NIV following an acute admission with hypercapnic respiratory failure

    Article • November 2019, BMJ

    Dr Ahilanandan Dushianthan

  97. Immunonutrition for Adults With ARDS: Results From a Cochrane Systematic Review and Meta-Analysis

    Article • Respiratory Care, September 2019, Daedalus Enterprises

    Dr Ahilanandan Dushianthan

  98. Insight into erythrocyte phospholipid molecular flux in healthy humans and in patients with acute respiratory distress syndrome

    Article • PLoS ONE, August 2019, PLOS

    Dr Ahilanandan Dushianthan

  99. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults

    Article • Cochrane Database of Systematic Reviews, January 2019, Wiley

    Dr Ahilanandan Dushianthan

  100. P200 A review of domiciliary non-invasive ventilation for patients with motor neurone disease (MND) in a regional centre

    Article • December 2018, BMJ

    Dr Ahilanandan Dushianthan

  101. P204 A retrospective study of home non-invasive ventilation for patients with severe COPD in a regional centre

    Article • December 2018, BMJ

    Dr Ahilanandan Dushianthan

  102. P208 The use of non-invasive ventilation in patients with community acquired pneumonia admitted to the intensive care unit

    Article • December 2018, BMJ

    Dr Ahilanandan Dushianthan

  103. Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures: a Cochrane systematic review

    Article • Perioperative Medicine, December 2018, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  104. Abnormal liver phosphatidylcholine synthesis revealed in patients with acute respiratory distress syndrome

    Article • Journal of Lipid Research, January 2018, Elsevier

    Dr Ahilanandan Dushianthan

  105. Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures

    Article • Cochrane Database of Systematic Reviews, September 2017, Wiley

    Dr Ahilanandan Dushianthan

  106. Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial

    Article • The Lancet Respiratory Medicine, June 2017, Elsevier

    Dr Ahilanandan Dushianthan

  107. Abstracts

    Article • Anaesthesia, January 2017, Wiley

    Dr Ahilanandan Dushianthan

  108. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults

    Article • Cochrane Database of Systematic Reviews, January 2016, Wiley

    Dr Ahilanandan Dushianthan

  109. Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome

    Article • November 2014, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  110. Perceptions of diagnosis and management of patients with acute respiratory distress syndrome: a survey of United Kingdom intensive care physicians

    Article • BMC Anesthesiology, October 2014, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  111. Phospholipid composition and kinetics in different endobronchial fractions from healthy volunteers

    Article • BMC Pulmonary Medicine, February 2014, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  112. Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a Cochrane Systematic Review † †This review is an abridged version of a Cochrane Review previously published in the Cochrane Database of Systematic Review...

    Article • British Journal of Anaesthesia, October 2013, Elsevier

    Dr Ahilanandan Dushianthan

  113. Proceedings of the Anaesthetic Research Society Meeting

    Article • British Journal of Anaesthesia, May 2013, Elsevier

    Dr Ahilanandan Dushianthan

  114. Perioperative buffered versus non-buffered fluid administration for surgery in adults

    Article • December 2012, Wiley

    Dr Ahilanandan Dushianthan

  115. S18 Bronchoalveolar Lavage, Tracheal Wash and Induced Sputum Surfactant Phospholipid Kinetics from Healthy Volunteers

    Article • Thorax, November 2012, BMJ

    Dr Ahilanandan Dushianthan

  116. S58 Surfactant Phospholipid Kinetics in Patients with Acute Respiratory Distress Syndrome (ARDS)

    Article • Thorax, November 2012, BMJ

    Dr Ahilanandan Dushianthan

  117. S65 Raised CK Levels in Severe Asthmatics Admitted to the Critical Care Unit- A Retrospective Cohort Analysis

    Article • Thorax, November 2012, BMJ

    Dr Ahilanandan Dushianthan

  118. Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery

    Article • Cochrane Database of Systematic Reviews, November 2012, Wiley

    Dr Ahilanandan Dushianthan

  119. ESICM 2012 MONDAY SESSIONS 15 October, 2012

    Article • Intensive Care Medicine, October 2012, Springer Science + Business Media

    Eric Hoste, Dr Ahilanandan Dushianthan

  120. Exogenous Surfactant Therapy in Acute Lung Injury/Acute Respiratory Distress Syndrome: The Need for a Revised Paradigm Approach

    Article • Journal of Cardiothoracic and Vascular Anesthesia, October 2012, Elsevier

    Dr Ahilanandan Dushianthan

  121. Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome - where do we go from here?

    Article • Critical Care, January 2012, Springer Science + Business Media

    Dr Ahilanandan Dushianthan

  122. Acute respiratory distress syndrome and acute lung injury

    Article • Postgraduate Medical Journal, June 2011, BMJ

    Dr Ahilanandan Dushianthan

  123. Unusual case of unilateral whiteout on chest radiograph with evidence of previous pulmonary tuberculosis exposure

    Article • Respiratory Medicine CME, January 2011, Elsevier

    Dr Ahilanandan Dushianthan

  124. Nocturia, enuresis and snoring: an unusual combination in an adult?

    Article • British Journal of Hospital Medicine, September 2010, Mark Allen Group

    Dr Ahilanandan Dushianthan

  125. Multiple pulmonary micronodules in a patient with Crohn's disease

    Article • BMJ Case Reports, August 2010, BMJ

    Dr Ahilanandan Dushianthan

  126. Outcome Of A Cohort Of Older Population With COPD, Admitted With Hypercapnaeic Respiratory Failure And Acidosis

    Article • May 2010, American Thoracic Society

    Dr Ahilanandan Dushianthan

  127. Observed Other Primary Malignancies In Patients With Lung Cancer

    Article • May 2010, American Thoracic Society

    Dr Ahilanandan Dushianthan

  128. Summer-type relapsing fever (hypersensitivity pneumonitis) secondary to Cladosporium herbarum in the domestic environment

    Article • Respiratory Medicine CME, January 2010, Elsevier

    Dr Ahilanandan Dushianthan

  129. Developmental Regulation of p66ShcIs Altered by Bronchopulmonary Dysplasia in Baboons and Humans

    Article • American Journal of Respiratory and Critical Care Medicine, June 2005, American Thoracic Society

    Dr Ahilanandan Dushianthan

  130. Are ColonialHaemophilus influenzaeResponsible for Exacerbations of Chronic Obstructive Pulmonary Disease After All?

    Article • American Journal of Respiratory and Critical Care Medicine, January 2005, American Thoracic Society

    Dr Ahilanandan Dushianthan